Inventor · disambiguated record
Julio Mulero
Also filed as: MULERO JULIO · MULERO JULIO J
15 granted patents·10 pending applications·52 citations·filing 1999–2024
90Inventor score
Top patents by PatentIndex Score
25 records- 0186US2024336958A1Se33 mutations impacting genotype concordanceLIFE TECHNOLOGIES CORP·Filed 2024·Application pending·0 cites
- 0284US9090946B2SE33 mutations impacting genotype concordanceGREEN ROBERT·Filed 2011·Granted Jul 28, 2015·2 cites·6 claims
- 0384US6476211B1Methods and materials relating to CD39-like polypeptidesHYSEQ INC·Filed 2000·Granted Nov 5, 2002·12 cites·11 claims
- 0483US11248256B2SE33 mutations impacting genotype concordanceLIFE TECHNOLOGIES CORP·Filed 2017·Granted Feb 15, 2022·1 cites·19 claims
- 0583US6335013B1Methods and materials relating to CD39-like polypeptidesHYSEQ INC·Filed 2000·Granted Jan 1, 2002·11 cites·17 claims
- 0681US8409806B2Allelic ladder lociGREEN ROBERT·Filed 2010·Granted Apr 2, 2013·2 cites·24 claims
- 0779US11913066B2SE33 mutations impacting genotype concordanceLIFE TECHNOLOGIES CORP·Filed 2022·Granted Feb 27, 2024·0 cites·8 claims
- 0874US8637655B2Amelogenin SNP on chromosome XMULERO JULIO·Filed 2010·Granted Jan 28, 2014·4 cites·5 claims
- 0973US10597707B2Multiplex Y-STR analysisLIFE TECHNOLOGIES CORP·Filed 2015·Granted Mar 24, 2020·1 cites·14 claims
- 1069US2009004662A1Method and compositions for nucleic acid amplificationAPPLERA CORP·Filed 2008·Application pending·0 cites
- 1167US6858207B2Methods and materials relating to novel CD39-like polypeptidesNUVELO INC·Filed 2002·Granted Feb 22, 2005·3 cites·3 claims
- 1265US12378601B2Multiplex Y-STR analysisLIFE TECHNOLOGIES CORP·Filed 2020·Granted Aug 5, 2025·0 cites·10 claims
- 1362US2016010146A1Se33 mutations impacting genotype concordanceLIFE TECHNOLOGIES CORP·Filed 2015·Application pending·0 cites
- 1462US2013109023A1Method and composition for nucleic acid amplificationMULERO JULIO J·Filed 2012·Application pending·0 cites
- 1561US2014065613A1Multiplex Y-STR AnalysisLIFE TECHNOLOGIES CORP·Filed 2013·Application pending·0 cites
- 1660US11293059B2Mesylate based master mixLIFE TECHNOLOGIES CORP·Filed 2018·Granted Apr 5, 2022·0 cites·31 claims
- 1758US2016237484A1Method and composition for nucleic acid amplificationAPPLIED BIOSYSTEMS LLC·Filed 2016·Application pending·0 cites
- 1855US9260757B2Human single nucleotide polymorphismsLIFE TECHNOLOGIES CORP·Filed 2015·Granted Feb 16, 2016·0 cites·4 claims
- 1952US9029088B2Human single nucleotide polymorphisms within CODIS loci D13S317, TH01, vWA, D12S391, and D6S1043MULERO JULIO·Filed 2010·Granted May 12, 2015·0 cites·4 claims
- 2050US2005192215A1Methods and materials relating to novel polypeptides and polynucleotidesFiled 2002·Application pending·0 cites
- 2149US6387645B1Methods and materials relating to novel CD39-like polypeptidesHYSEQ INC·Filed 1999·Granted May 14, 2002·12 cites·18 claims
- 2249US2004248156A1Methods and materials relating to novel C1q domain-containing polypeptides and polynucleotidesFiled 2004·Application pending·0 cites
- 2348US2003175752A1Methods and materials relating to CD39-like polypeptidesFiled 2002·Application pending·0 cites
- 2447US2002173005A1Methods and materials relating to novel CD39-like polypeptidesHYSEQ INC·Filed 2002·Application pending·0 cites
- 2540US6447771B1Methods and materials relating to novel CD39-like polypeptidesHYSEQ INC·Filed 1999·Granted Sep 10, 2002·4 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Julio Mulero files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →